Finance

Lists
4582:TYO
Symbio Pharmaceuticals Ltd
Â¥64.00
+1.59%
(+1.00) 1D
Aug 28, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4582...
Open
Â¥63
High
Â¥64
Low
Â¥62
Mkt. cap
5.14B
Avg. vol.
634.07K
Volume
251.60K
52-wk high
Â¥229
52-wk low
Â¥60
EPS
-Â¥98
Shares outstanding
82.40M
No. of employees
91
Open
Â¥63
High
Â¥64
Low
Â¥62
Mkt. cap
5.14B
Avg. vol.
634.07K
Volume
251.60K
52-wk high
Â¥229
52-wk low
Â¥60
EPS
-Â¥98
Shares outstanding
82.40M
No. of employees
91
About Symbio Pharmaceuticals Ltd
CEO-
Employees91
FoundedMar 25, 2005
HeadquartersMinato City, Tokyo, Japan
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
324.17M
336.19M
233.46M
236.50M
Cost of goods sold
122.29M
84.64M
60.63M
71.19M
Cost of revenue
122.29M
84.64M
60.63M
71.19M
Research and development expenses
868.70M
846.40M
1.99B
1.01B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
518.54M
506.73M
522.11M
453.89M
Operating expense
1.39B
1.35B
2.51B
1.46B
Total operating expenses
1.51B
1.44B
2.57B
1.53B
Operating income
-1.19B
-1.10B
-2.34B
-1.29B
Other non operating income
-1.57M
14.49M
-6.26M
86.04M
EBT including unusual items
-1.20B
-1.19B
-2.39B
-1.21B
EBT excluding unusual items
-1.20B
-1.09B
-2.39B
-1.22B
Income tax expense
-3.66M
18.88M
13.97M
4.42M
Effective tax rate
0.30%
-1.58%
-0.58%
-0.36%
Other operating expenses
-
-
-
-
Net income
-1.20B
-1.21B
-2.40B
-1.22B
Net profit margin
-369.09%
-360.02%
-1,028.60%
-515.23%
Earnings per share
-
-
-
-
Interest and investment income
1.73M
653.00K
2.25M
-
Interest expense
-29.04M
-11.12M
-16.63M
-17.96M
Net interest expenses
-27.31M
-10.47M
-14.38M
-17.96M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps